Replies to post #72317 on Cytodyn Inc (CYDY)

[ohm20]

Why hasn't the NIH released the actual data for remdesivir?

Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (p=0.059)

p=.059 is not statistically significant.

The Chinese trial showed no difference in viral load between remdesivir and placebo. If an antiviral doesn't reduce the virus then it doesn't work.

The NIH trial doesn't even list viral load as a trial marker.

[Monroe1]

AZT is a disaster in itself. You are better off not taking it. Big Pharma does not shoot for a cure. The go for half assed solutions so you have to buy a lot of it, and many times the dosage gets increased. Then the side effects kick in and low and behold you find yourself taking another medication for the side effects. Now that is the recipe for a corrupt yet hugely profitable business model.

There is not much money in death or in cures. Keep the patient alive enough to milk them good and plenty. That's how the game works. Leronlimab changes all of that. This is a very interesting battle going on. Rarely if ever has the big pharma and their FDA stooges ever been exposed to this extent. I dare say they are a bit panicked and now is the time to light the fire as far as citizen pressure goes. Our CEO understands this and is very similar to Trump; smart, diplomatic and savvy to the competition.